Komulainen A, Olson M E
Department of Animal Care Services, University of Calgary, Alberta, Canada.
Am J Vet Res. 1991 Apr;52(4):585-8.
Antagonism of ketamine-xylazine (85 mg of ketamine/kg of body weight and 15 mg of xylazine/kg, IM) anesthesia in rats by yohimbine (YOH; 1, 5, 10, and 20 mg/kg, IP), tolazoline (TOL; 10, 20, or 50 mg/kg, IP), 4-aminopyridine (4-AP; 1 or 5 mg/kg, IP), or a combination of yohimbine and 4-aminopyridine (YOH:4-AP, 1 mg/kg:1 mg/kg or 5 mg/kg:1 mg/kg, IP) was studied. All dosages of YOH, TOL, 4-AP, and YOH:4-AP reduced the time to appearance of corneal and pedal reflexes. Only TOL was effective in reducing time to appearance of the crawl reflex and recovery time. Yohimbine, 4-AP, YOH:4-AP, and TOL were effective in reversing respiratory depression caused by ketamine-xylazine anesthesia, but anesthetic-induced hypothermia was not antagonized. When given to non-anesthetized rats, the antagonists had little influence on respiratory rate, but all antagonists caused significant (P less than 0.05) reduction in core body temperature for at least 90 minutes. When YOH was used as an anesthetic antagonist at dosage of 20 mg/kg, 20% mortality was observed and was attributable to acute respiratory arrest. The use of 4-AP and YOH:4-AP at the dosages studied induced moderate to severe muscular tremors. In conclusion, TOL at dosage of 20 mg/kg given IP, appears to be an appropriate antagonist for ketamine-xylazine anesthesia in rats.
研究了育亨宾(YOH;1、5、10和20毫克/千克,腹腔注射)、妥拉唑啉(TOL;10、20或50毫克/千克,腹腔注射)、4-氨基吡啶(4-AP;1或5毫克/千克,腹腔注射)或育亨宾与4-氨基吡啶的组合(YOH:4-AP,1毫克/千克:1毫克/千克或5毫克/千克:1毫克/千克,腹腔注射)对氯胺酮-赛拉嗪(85毫克氯胺酮/千克体重和15毫克赛拉嗪/千克,肌肉注射)麻醉大鼠的拮抗作用。所有剂量的YOH、TOL、4-AP和YOH:4-AP均缩短了角膜反射和足趾反射出现的时间。只有TOL能有效缩短爬行反射出现的时间和恢复时间。YOH、4-AP、YOH:4-AP和TOL能有效逆转氯胺酮-赛拉嗪麻醉引起的呼吸抑制,但不能拮抗麻醉诱导的体温过低。给未麻醉的大鼠注射拮抗剂时,对呼吸频率影响不大,但所有拮抗剂均使核心体温显著降低(P<0.05),至少持续90分钟。当以20毫克/千克的剂量使用YOH作为麻醉拮抗剂时,观察到20%的死亡率,这归因于急性呼吸骤停。在所研究的剂量下使用4-AP和YOH:4-AP会引起中度至重度肌肉震颤。总之,腹腔注射20毫克/千克剂量的TOL似乎是大鼠氯胺酮-赛拉嗪麻醉的合适拮抗剂。